Xarelto (rivaroxaban) approved for stroke prevention in atrial fibrillation 2 years ago | Heart and Vascular Health | Scoop.it

#OnThisDay (11/4/2011) two years ago the first Factor Xa inhibitor and second novel oral anticoagulant (NOAC) was approved to prevent stroke in atrial fibrillation.  We now have three NOACs available.